Abstract:Background: Parkinson's disease (PD) is characterized by the selective death of dopaminergic neurons in the substantia nigra. Recently, NLRP3 inflammasome and pyroptosis were found to be associated with PD. Cyclosporine A (CsA), an immunosuppressant, reduces neuronal death in PD. However, CsA could hardly pass through the blood-brain barrier (BBB) and high dose is associated with severe side effects and toxicity. N-methyl-4-isoleucine-cyclosporine (NIM811) is a CsA derivate that can pass through the BBB. However, little is known about its effect on PD. Objective: The objectives of this study were to explore the mechanism of rotenone-induced cell damage and to examine the protective effects of NIM811 on the neurotoxicity of a Parkinson-like in vitro model induced by rotenone. Methods: Murine hippocampal HT22 cells were cultured with the mitochondrial complex I inhibitor rotenone, a widely used pesticide that has been used for many years as a tool to induce a PD model in vitro and in vivo and proven to be reproducible. NIM811 was added to the culture media 3 h prior to the rotenone incubation. Cell viability was determined by resazurin assay, reactive oxygen species (ROS) production by dihydroethidine (DHE), and mitochondrial membrane potential by tetramethyl rhodamine methyl ester (TMRM). TUNEL and caspase-1 immunofluorescent double staining was used to detect pyroptosis. NLRP3, caspase-1, pro-caspase-1, GSDMD, and interleukin-18 (IL-18) were measured using Western blotting after 24 h of rotenone incubation. The reactivity of interleukin-1 beta (IL-1 beta) was determined by ELISA. Results: Our results demonstrated that rotenone caused more than 40% of cell death, increased ROS production, and reduced mitochondrial membrane potential, while NIM811 reversed these alterations. Immunofluorescent double staining showed that rotenone increased the percentage of caspase-1 and TUNEL double-labelled cells, an indication of pyroptosis, after 24 h of incubation. The protein expression of NLRP3, caspase-1, pro-caspase-1, GSDMD, IL-18, and IL-1 beta was significantly increased after 24 h of rotenone incubation. NIM811 suppressed rotenone-induced pyroptosis and downregulated the protein expression of NLRP3, caspase-1, pro-caspase-1, GSDMD, IL-1 beta, and IL-18. Conclusion: These results provide evidence that rotenone activates the NLRP3 inflammomere and induces pyroptosis. NIM811 protects the cell from rotenone-induced damage and inhibits NLRP3 inflammasome and pyroptosis. NIM811 might serve as a potential therapeutic drug in the treatment of PD.

Cell Cycle Regulation Of Dna Polymerase Beta In Rotenone-Based Parkinson'S Disease Models

Identification of Novel Proteins Affected by Rotenone in Mitochondria of Dopaminergic Cells

Novel Biomolecular Information in Rotenone-Induced Cellular Model of Parkinson's Disease.

Rotenone-Induced Model of Parkinson's Disease: Beyond Mitochondrial Complex I Inhibition

DNA polymerase-beta is required for 1-methyl-4-phenylpyridinium-induced apoptotic death in neurons.

Glyceraldehyde-3-phosphate Dehydrogenase: Activity Inhibition and Protein Overexpression in Rotenone Models for Parkinson's Disease

Suppression of NLRP3 Inflammasome, Pyroptosis, and Cell Death by NIM811 in Rotenone-Exposed Cells as an in vitro Model of Parkinson's Disease

DNA polymerase-β is required for 1-methyl-4-phenylpyridinium-induced apoptotic death in neurons

Resveratrol Partially Prevents Rotenone-Induced Neurotoxicity in Dopaminergic SH-SY5Y Cells through Induction of Heme Oxygenase-1 Dependent Autophagy

The Contribution of Cdc2 in Rotenone-Induced G2/M Arrest and Caspase-3-dependent Apoptosis.

Extracellular Signal-Regulated Kinases 1 and 2 Regulating Rotenone-Induced Injury in Pheochromocytoma Cells

Rotenone affects p53 transcriptional activity and apoptosis via targeting SIRT1 and H3K9 acetylation in SH‐SY5Y cells

The Role of Autophagy in Parkinson's Disease: Rotenone-Based Modeling

Rotenone Induction of Hydrogen Peroxide Inhibits Mtor-Mediated S6k1 and 4E-Bp1/eif4e Pathways, Leading to Neuronal Apoptosis

2′,3′-Dideoxycytidine Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease

Enhancing Beta-Catenin Activity via GSK3beta Inhibition Protects PC12 Cells against Rotenone Toxicity through Nurr1 Induction

Mechanisms of rotenone-induced neurotoxicity in PC 12 cells

P38mapk/p53-Mediated Bax Induction Contributes to Neurons Degeneration in Rotenone-Induced Cellular and Rat Models of Parkinson’s Disease

Pyroptosis mediated by Parkin-NLRP3 negative feedback loop contributed to Parkinson's disease induced by rotenone

Polydatin Protects SH-SY5Y in Models of Parkinson's Disease by Promoting Atg5-mediated but Parkin-Independent Autophagy.

Minocycline Protects Against Rotenone-Induced Neurotoxicity Correlating with Upregulation of Nurr1 in a Parkinson's Disease Rat Model